Refreshing results…
Plitidepsin as an Immunomodulator against Respiratory Viral Infections
UploadDefining the risk of SARS-CoV-2 variants on immune protection
UploadAdvances and gaps in SARS-CoV-2 infection models
Download from doi.orgVirus-induced senescence is a driver and therapeutic target in COVID-19
Download from www.nature.comDrug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
UploadCOVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
Download from www.nature.comPlitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
UploadDiscovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
Download from www.nature.comMissing publications? Search for publications with a matching author name.